Authors
Latest:
DIY Blood Sampling for Pediatric Clinical Trials—The Patients PerspectiveA recent survey shows that 40% of pediatric trials conducted between 2008 and 2011 were never finished or published. One of the main challenges is the need to collect multiple sequential blood samples. Which, mircosampling, could be the answer to.
Latest:
DIY Blood Sampling for Pediatric Clinical Trials—The Patients PerspectiveA recent survey shows that 40% of pediatric trials conducted between 2008 and 2011 were never finished or published. One of the main challenges is the need to collect multiple sequential blood samples. Which, mircosampling, could be the answer to.
Latest:
The Biotech Reset: Navigating the Path ForwardWebinar Date/Time: Thursday, May 2nd, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Latest:
The Critical Importance of Real-Time Access to Clinical Study PerformanceThe need to see real-time study performance is vital, as teams focus on meeting timelines and ensuring resources are appropriately allocated, writes EVP of WCG, Jonathan Zung.
Latest:
Alzheimer’s Research Finds New BeginningsDespite mounting frustrations in drug R&D for Alzheimer's disease, emerging biopharma firms are still pursuing AD therapies with new science, and different preclinical and clinical trial models.
Latest:
The Challenges in Fulfilling the Promise of Precision OncologyOutlining the three critical challenges that need to be addressed to make personalized cancer treatment a reality.
Latest:
Delivering on the Promise of Precision Medicine: The Critical Role of Specialty LabsDarren Davis, Senior Vice President at Precision for Medicine, explores the need for specialty labs in cancer treatment plans.
Latest:
Clinical Supply–Why Putting Patients First MattersThe time to stop hammering square pegs into round holes in terms of design strategy has come, as sponsors embrace an adaptive supply chain approach.
Latest:
Digitalization Trends in Tackling the Complexity of Clinical Trials for Patients with Multiple Health ConditionsDigitalization has been progressively facilitating increased access to trials by helping alleviate logistical burdens, but not much is known about how these tools can address the needs of patients with multiple chronic conditions.
Latest:
Dementia Doesn’t Discriminate—Neither Should Dementia ResearchCherry-picking a small group here and a dementia risk factor there won't reflect the way that dementia affects people from every walk of life, writes CEO & Founder of Savonix, Mylea Charvat.
Latest:
Building A Better FSPOutlining the three concerns communicated the most when it comes to implementing an FSP outsourcing strategy.
Latest:
Building A Better FSPOutlining the three concerns communicated the most when it comes to implementing an FSP outsourcing strategy.
Latest:
Operationalizing Complex Clinical TrialsInsights from a roundtable at Halloran’s Clinical Operations Retreat for Executives covering major topics in both clinical design and execution.
Latest:
On your Mark…Get Set…Go?...or Go!Understanding how your strategy will be re-shaped post-COVID.
Latest:
Advancing Human Healthcare Through Accessible Trial Data and AnalyticsThe Clinical Study Data Request consortium is actively pursuing platform interoperability to allow data to be merged and analyzed as an important step for advancing human healthcare.
Latest:
Technology’s Role in Managing a Compassionate Use ProgramViiV Healthcare outlines techniques and tips for implementing a technology-based process for handling compassionate use requests.
Latest:
The ICR-CRM-IQVIA Research Network Collaboration ExperienceA discussion of the impact of a strategic alliance in to facilitate operational success at the clinical trial site level in Malaysia.
Latest:
Is Retraining on Good Clinical Practice Guidelines Effective?Survey results from Clinical Research Malaysia’s GCP refresher workshop.
Latest:
Clinical Trials in the Baltic StatesThe region has an appropriate population size, solid infrastructure, experienced nvestigators, and short timelines.
Latest:
The Importance of Site SelectionCase study focused on quest for potential Parkinson’s biomarker highlights opportunities and challenges in site selection.
Latest:
The Importance of Site SelectionCase study focused on quest for potential Parkinson’s biomarker highlights opportunities and challenges in site selection.
Latest:
Introducing PALADINFirst-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
Latest:
Beyond Hard Outcomes: The Next Era in Heart Failure R&DWhy and how FDA is funding a digital biomarkers study that centers on quality of life for patients with heart failure.
Latest:
Virtual Clinical Studies: Finding a Path to ExecutionThe regulatory path for virtual studies is nebulous and potentially difficult to navigate-finding a way forward requires a thorough understanding of the terrain and how to apply existing legal frameworks.
Latest:
Updates on Drug and Device Regulatory Reform in ChinaOutlining the nation’s key changes and current requirements in processing investigational and new drug applications.
Latest:
Updates on Drug and Device Regulatory Reform in ChinaOutlining the nation’s key changes and current requirements in processing investigational and new drug applications.
Latest:
Updates on Drug and Device Regulatory Reform in ChinaOutlining the nation’s key changes and current requirements in processing investigational and new drug applications.
Latest:
Updates on Drug and Device Regulatory Reform in ChinaOutlining the nation’s key changes and current requirements in processing investigational and new drug applications.
Latest:
Labeling Challenges From EU Annex VIA new era for clinical trials supply compliance in the EU is almost here.
